Peptide hormone

Adrenomedullin

Adrenomedullin is a peptide hormone initially identified in human pheochromocytoma tissue. Cellular studies examine its recognition by receptor complexes containing a RAMP protein. Research encompasses molecular identity, signaling and experimental circulatory responses.

This is a research reference, not a product offered in the Asciende catalog. Published studies do not establish the identity, purity or availability of a commercial preparation.

Concentration, tissue and vascular response

Keep controls beside the described effect. Response direction alone does not establish selectivity or applicability beyond the model.

Was the response measured at a receptor, in isolated tissue or in intact circulation?
Do the preparation and context support attribution of the readout to the studied entity?
Does the comparison preserve species, time and method or change more than one variable?

Find readings for this question

Mechanism described in the literature

In cellular models, association of the receptor historically called CRLR with RAMP2 characterized an adrenomedullin receptor. Complex composition matters: the main receptor protein's name alone does not describe ligand recognition.

Other names in the literature

Adrenomedullin
ADM
AM

What discovery established

The 1993 identification tracked a cyclic AMP response in platelets while analyzing biological material. The name refers to its presence in the adrenal medulla. Discovery tissue does not necessarily define every expression site, and the starting extract must be distinguished from the subsequently characterized entity.

Complete molecule versus fragment

A later study specifically examined human adrenomedullin-(15–22). This fragment produced a pressor response in rats that contrasted with the complete molecule's reported profile. Preserving a structural region therefore does not guarantee preserving the parent peptide's behavior.

Species and mechanism cannot be omitted

The fragment study found differences between rats and cats and examined catecholamine-related signaling. These results belong to the fragment and the specified models. Grouping them under adrenomedullin without qualification would mix entities and conceal an important experimental discrepancy.

Questions and answers

Can ADM and AM refer to adrenomedullin?

Yes, but abbreviations must be interpreted within each publication. The full name and molecular form are more precise.

Does an adrenomedullin fragment necessarily retain its response?

No. The investigated fragment showed different behavior and species differences; its results do not automatically apply to the complete molecule.